Assessment of inflammatory markers and their association with disease mortality in severe COVID-19 patients of tertiary care hospital in South India

被引:6
|
作者
Devang, Nayana [1 ]
Sreelatha, Souparnika [2 ]
Mamatha, B., V [1 ]
机构
[1] Kanachur Inst Med Sci & Res Ctr, Dept Biochem, Mangalore Univ Rd, Mangaluru 575018, Karnataka, India
[2] NITTE Univ, KS Hegde Med Acad, Dept Biochem, Mangaluru 575018, Karnataka, India
关键词
COVID-19; Inflammation; C-reactive protein; Lactate dehydrogenase; Ferritin; Oxygen saturation; Mortality; LACTATE-DEHYDROGENASE;
D O I
10.1186/s43168-022-00159-1
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: COVID-19 infection involves a complex interplay of the immunological and inflammatory responses. Low blood-oxygen levels have been a hallmark in COVID-19 patients. The lung tissue damage infiltered by the viral-mediated inflammation decreases oxygen saturation to cause silent hypoxia and cell death. This study aimed to evaluate the association of inflammatory biomarkers with oxygen saturation (SpO(2)) and mortality in severe COVID-19 patients. Methods: A total of 190 severe COVID-19 patients were included in this study after confirmed by the RT-PCR assay. The laboratory tests were performed for biochemical assessment. Serum levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), and ferritin were determined and compared between survivors and nonsurvivors using independent sample t-test. The correlation of these inflammatory markers was studied using Spearman's correlation, and their association with mortality was studied using logistic regression. Results: All the COVID-19 patients were severe with SpO(2)< 90% and respiratory rate > 30/min. While the serum levels of CRP, LDH, ferritin, aspartate transaminase (AST), urea, and random blood sugar (RBS) were elevated, hemoglobin (Hb) and SpO(2) levels were reduced in COVID-19 patients. LDH and ferritin levels were significantly higher in nonsurvivors compared to survivors with p values of 0.001 and 0.022 respectively. Spearman's correlation showed a significant correlation of the inflammatory markers with SpO(2), serum electrolytes (potassium, chloride), liver enzymes (AST and alanine transaminase (ALT)), and markers of kidney damage (urea, creatinine). Conclusion: Inflammatory markers could effectively discriminate the risk of mortality in severe COVID-19 patients. As CRP, LDH, and ferritin levels determine the tissue oxygen availability, they seem to be valuable biomarkers in the prognosis of COVID-19.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Willingness of medical students to volunteer during the Covid-19 pandemic: Assessment at a tertiary care hospital in India
    Sra, Manraj
    Gupta, Amulya
    Jaiswal, Abhishek
    Yadav, Kapil
    Goswami, Anil
    Goswami, Kiran
    NATIONAL MEDICAL JOURNAL OF INDIA, 2022, 35 (04): : 247 - 251
  • [42] Frequency of extra pulmonary complications in critically ill COVID-19 patients and their association with inflammatory markers and hypoxia: Retrospective analysis at a tertiary care hospital in Karachi, Pakistan
    Hanif, Sadaf
    Sohaib, Muhammad
    Talha, Syed
    Rayani, Asma
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (06) : 1824 - 1829
  • [43] The Association of Psychosocial Manifestations and Quality of Life With Inflammatory Markers in SARS-CoV-2 Patients: A Study From a Dedicated COVID-19 Tertiary Care Hospital
    Kumar, Kuldeep
    Srivastava, Shruti
    Meena, Akshay
    Avasthi, Rajnish K.
    Kashyap, Bineeta
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [44] Reanalyzing the Mortality Analysis of COVID-19 Deaths in a Tertiary Care Center in India
    Anand, Abhijeet
    Panghal, Reecha
    Kaler, Paridhi
    Saigal, Saurabh
    Panda, Rajesh
    Kodamanchili, Saiteja
    Bhardwaj, Krishnkant
    Gowthaman, T. B.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (10)
  • [45] Prognostic markers and out comes in severe leptospirosis in a tertiary care hospital from south India
    Prabhu, M.
    Valsalan, R.
    Ks, N.
    Ramachandran, B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E389 - E389
  • [46] The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
    Luis Ayerbe
    Carlos Risco-Risco
    Salma Ayis
    Internal and Emergency Medicine, 2020, 15 : 1501 - 1506
  • [47] The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
    Ayerbe, Luis
    Risco-Risco, Carlos
    Ayis, Salma
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (08) : 1501 - 1506
  • [48] The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India
    Hazra, Druti
    Chawla, Kiran
    Shenoy, Vishnu P.
    Pandey, Akhilesh K.
    Nayana, S.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (08) : 1095 - 1098
  • [49] Mortality of Patients With Severe COVID-19 in the Intensive Care Unit: An Observational Study From a Major COVID-19 Receiving Hospital
    Rahim, Fawad
    Amin, Said
    Noor, Mohammad
    Bahadur, Sher
    Gul, Huma
    Mahmood, Afsheen
    Usman, Muhammad
    Khan, Muhammad Asif
    Ullah, Raza
    Shahab, Khalid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [50] Association of elevated inflammatory markers and severe COVID-19 A meta-analysis
    Ji, Pan
    Zhu, Jieyun
    Zhong, Zhimei
    Li, Hongyuan
    Pang, Jielong
    Li, Bocheng
    Zhang, Jianfeng
    MEDICINE, 2020, 99 (47)